Bill Booth kindly invited me on to his podcast to discuss health and medicine. Bill is one of the founders of Radical Americas, an academic network for scholars and activists with interests in radicalism in the Western Hemisphere.
The ADHS is pleased to announce that the editorship of its journal, *The Social History of Alcohol and Drugs*, will be taken over by Prof. Nancy D. Campbell (Rensselaer Polytechnic Institute), Prof. David Herzberg (Buffalo) and Dr. Lucas Richert (Strathclyde). The society would also like to express its gratitude for the work that outgoing editor, […]
The ADHS is excited to announce that its next bi-annual conference will be held between 12 and 15 June 2019, at the David F. Musto Center for Drug Policy Studies, Shanghai University, China. The conference will be organised by Prof. Jim Mills, of the University of Strathclyde and Prof. Yong-an Zhang of Shanghai University, who […]
Here is a snapshot of the past week in Big Pharma news. This is coming at you a little early because of the Christmas slowdown. Happy holidays.
To kick off:
The drug industry spent big!
Here’s another one on the lobbying money spent over the past months and years…
A lot of money was splashed out. ‘“Does that surprise you?” said Billy Tauzin, the former PhRMA CEO who ran the organization a decade ago as Obamacare loomed. Whenever Washington seems interested in limiting drug prices, he said, “PhRMA has always responded by increasing its resources.”’
In Canada, there’s efforts to reduce “sticker shock” when purchasing drugs.
“A Toronto family doctor thinks she has a prescription for the nasty surprise many patients experience when they go to the pharmacy and learn just how much their medications will cost.”
What about other countries besides the US? Say, Poland. It spends a lot on pharmaceuticals – but on the right drugs?
Then, more on opioids. Ravaged by Opioids!
Away from the young, and to the old: could drugs slow ageing?
“Some pharmaceutical companies are exploring whether [certain] genetic traits could be used to create anti-ageing drugs.”
And in BC, Canada: illicit placenta and stem cell therapies were seized!!!
‘The drugs confiscated from Before & After Beauty Lab on Hazelbridge Way “may pose serious risks to health,” according to a Health Canada press release.’
There was a also mysterious double murder in the world of Big Pharma!
Here at Strathclyde, CMAC welcomes Pfizer as newest partner…
“CMAC (Continuous Manufacturing and Advanced Crystallisation), a pre-competitive consortium led by the University of Strathclyde to accelerate progress in pharmaceutical manufacturing, announces that Pfizer Inc has joined as a strategic member, alongside GSK, AZ, Novartis, Bayer, Takeda, Lilly and Roche.”
Lastly, St Thomas University (Canada) is hiring a cannabis/marijuana scholar. As the cannabis industry consolidates and the medicine is refined further, the job is a useful chance to contribute to the discussion. And it looks spectacular.
Here is a flyer for my book on Big Pharma! Cheap, cheap, cheap.
A round up of the recent Big Pharma and FDA stories.
Antibiotics in Farm Animals Drop:
Teva Pharmaceuticals is being reshaped:
Rebooting the FDA:
Top 5 Stories of 2017:
FDA clears the Apple watch:
The FDA is going to go after price gouging:
And supplement makers:
Bipartisanship on Drug Prices:
I’ve more than likely missed some angles and stories. Drop me a line if you have suggestions.
Here’s a flyer for 30% off my Big Pharma book!
The deadline for the University of Strathclyde’s Cannabis: Global Histories cfp is 7 days away! https://www.strath.ac.uk/humanities/schoolofhumanities/history/cannabisglobalhistories/